These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9116653)

  • 1. An automated radiopharmaceutical dispenser.
    Plascjak PS; Kim K; Meyer W; Divel J; Der M; Eckelman WC
    Appl Radiat Isot; 1997 Mar; 48(3):345-8. PubMed ID: 9116653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional distribution of 2-deoxy-2[18F]-fluoro-D-glucose for metabolic imaging using positron emission tomography.
    Alagona P; Hart DT; Eikman EA
    Int J Card Imaging; 1994 Jun; 10(2):137-43. PubMed ID: 7963752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies.
    Mejia AA; Nakamura T; Masatoshi I; Hatazawa J; Masaki M; Watanuki S
    J Nucl Med; 1991 Apr; 32(4):699-706. PubMed ID: 2013810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Simplicity or complexity of the radiopharmaceutical production process in the light of optimization of radiation protection of staff - 99mTc vs. 18F].
    Wrzesień M
    Med Pr; 2018 May; 69(3):317-327. PubMed ID: 29790486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple devices for dispensing [18F]FDG.
    O Park J; Lee H; Shin YS; Shin YH; Jin KH; Choe YS; Kim BT
    Appl Radiat Isot; 2005 Apr; 62(4):605-7. PubMed ID: 15701416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a radiopharmaceutical multidose dispenser for positron emission tomography: Risk assessment and mitigation measures for infection prevention.
    Karanfilovska D; Martin R; Barton H; Yap KS; Cheng A
    Infect Dis Health; 2020 Mar; 25(2):101-106. PubMed ID: 31911132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG).
    Drane WE; Nicole MW; Mastin ST; Kuperus JH
    Radiology; 1995 Nov; 197(2):341-2; discussion 343. PubMed ID: 7480674
    [No Abstract]   [Full Text] [Related]  

  • 8. High fluorine-18 labeled deoxyglucose uptake in sarcoidosis.
    Yasuda S; Shohtsu A; Ide M; Takagi S; Ogawa J; Mitomi T; Suzuki Y
    Clin Nucl Med; 1996 Dec; 21(12):983-4. PubMed ID: 8957624
    [No Abstract]   [Full Text] [Related]  

  • 9. Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images.
    Hübner KF; Buonocore E; Gould HR; Thie J; Smith GT; Stephens S; Dickey J
    Clin Nucl Med; 1996 Dec; 21(12):941-9. PubMed ID: 8957608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting quality control of [18F]FDG injection: bacterial endotoxins test, aluminum ions test and HPLC analysis for FDG and CIDG.
    Nakao R; Kida T; Suzuki K
    Appl Radiat Isot; 2005 Jun; 62(6):889-95. PubMed ID: 15799866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified calculation of MRglc using PET.
    Phillips RL; London ED
    J Nucl Med; 1997 Aug; 38(8):1334. PubMed ID: 9255178
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cerebral positron emission tomography with F18-fluorodeoxyglucose].
    Grupo PET de la SEMN.
    Rev Esp Med Nucl; 2002 Feb; 21(1):38-40. PubMed ID: 11821002
    [No Abstract]   [Full Text] [Related]  

  • 13. [Whole body positron emission tomography (PET) with (18F)-fluorodeoxyglucose].
    Grupo PET de la SEMN
    Rev Esp Med Nucl; 2002 Apr; 21(2):128-30. PubMed ID: 11879625
    [No Abstract]   [Full Text] [Related]  

  • 14. Diffuse F-18 FDG uptake in chronic thyroiditis.
    Yasuda S; Shohsu A; Ide M; Takagi S; Suzuki Y; Tajima T
    Clin Nucl Med; 1997 May; 22(5):341. PubMed ID: 9152546
    [No Abstract]   [Full Text] [Related]  

  • 15. Physiologic smoothing of blood time-activity curves for PET data analysis.
    Graham MM
    J Nucl Med; 1997 Jul; 38(7):1161-8. PubMed ID: 9225813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability Study of [18F]Fludeoxyglucose and [18F]Fluorocholine in Different Medical Devices for Intravenous Administration.
    Hallouard F; Sauze W; Emery S; Skanjeti A; Rioufol C; Fraysse M
    Curr Radiopharm; 2018; 11(2):138-146. PubMed ID: 29972107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated preparation of radiopharmaceuticals as a tool of radiation protection optimisation of staff.
    Budinský M; Vyšinský P; Synek S; Žilková K
    Ceska Slov Farm; 2020; 69(5-6):218-221. PubMed ID: 33736447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorbed dose estimates in positron emission tomography studies based on the administration of 18F-labeled radiopharmaceuticals.
    Mejia AA; Nakamura T; Itoh M; Hatazawa J; Ishiwata K; Ido T; Matsumoto M; Watabe H; Watanuki S; Seo S
    J Radiat Res; 1991 Sep; 32(3):243-61. PubMed ID: 1838773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injected dose in pediatric PET.
    Watson CC
    J Nucl Med; 2010 Oct; 51(10):1657; author reply 1657-8. PubMed ID: 20847164
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of oncology protocol using fluorine-18-FDG: one center's experience.
    Cronin V; Galantowicz P; Nabi HA
    J Nucl Med Technol; 1997 Mar; 25(1):66-9. PubMed ID: 9239608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.